S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
LON:GNS

Genus (GNS) Share Price, News & Analysis

GBX 1,787
-30.00 (-1.65%)
(As of 03/27/2024 09:27 PM ET)
Today's Range
1,765.26
1,811.72
50-Day Range
1,637
2,354
52-Week Range
1,478
2,984
Volume
46,321 shs
Average Volume
98,352 shs
Market Capitalization
£1.18 billion
P/E Ratio
3,503.92
Dividend Yield
1.79%
Price Target
GBX 4,500

Genus MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
151.8% Upside
GBX 4,500 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.08 out of 5 stars

GNS stock logo

About Genus Stock (LON:GNS)

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers technical services to farmers. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.

GNS Stock Price History

GNS Stock News Headlines

the most reliable asset on earth is making a comeback
Global tensions have been pushing the price of gold to all time highs… Just recently, gold peaked at a record $2,000 (and is now closer to $2,200). And there’s something else critical at play right now in the world’s largest asset. Because of these critical factors, a lot of massive investment institutions are now pumping more money into gold. And as we speak, some are even calling for a massive rally in the precious metal.
Estimating The Intrinsic Value Of Genus plc (LON:GNS)
Genus PLC
The AI Defense Stock Set to Soar
To protect our interests, The Pentagon has partnered with this small AI defense contractor - creating some of the most powerful AI defenses ever made.
Genus PLC GNS
A Look At The Fair Value Of Genus plc (LON:GNS)
Genus plc (GNS.L)
See More Headlines
Receive GNS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genus and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 3/28 Dividend
2/29/2024
Today
3/28/2024
Dividend Payable
3/28/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
3,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
GBX 4,500
High Stock Price Target
GBX 4,500
Low Stock Price Target
GBX 4,500
Potential Upside/Downside
+151.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
£33.40 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£673.10 million
Cash Flow
GBX 35.34 per share
Book Value
GBX 875 per share

Miscellaneous

Free Float
N/A
Market Cap
£1.18 billion
Optionable
Not Optionable
Beta
0.32
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Mr. Jorgen Kokke (Age 56)
    Chief Executive Officer & Director
    Comp: $574.04k
  • Ms. Alison Jane Henriksen ACA (Age 57)
    CFO & Executive Director
    Comp: $605k
  • Dr. Matt Culbertson
    Chief Operating Officer
  • Dr. Elena Rice
    Head of R&D and Chief Scientific Officer
  • Mr. Daniel William David Hartley
    Group General Counsel & Company Secretary
  • Ms. Angelle R. Rosata
    Group Human Resources Director
  • Mr. Jerry Thompson
    Chief Operating Officer of Genus ABS Beef
  • Dr. Nate Zwald
    Chief Operating Officer of Genus ABS Dairy
  • Andrew Thompson
    Head of ABS EMEA
  • Ms. Janet Duane
    Group Financial Controller

GNS Stock Analysis - Frequently Asked Questions

Should I buy or sell Genus stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Genus in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" GNS shares.
View GNS analyst ratings
or view top-rated stocks.

What is Genus' stock price target for 2024?

1 equities research analysts have issued 12 month price objectives for Genus' shares. Their GNS share price targets range from GBX 4,500 to GBX 4,500. On average, they predict the company's share price to reach GBX 4,500 in the next year. This suggests a possible upside of 151.8% from the stock's current price.
View analysts price targets for GNS
or view top-rated stocks among Wall Street analysts.

How have GNS shares performed in 2024?

Genus' stock was trading at GBX 2,170 on January 1st, 2024. Since then, GNS stock has decreased by 17.6% and is now trading at GBX 1,787.
View the best growth stocks for 2024 here
.

How often does Genus pay dividends? What is the dividend yield for Genus?

Genus announced a dividend on Thursday, February 22nd. Investors of record on Thursday, February 29th will be given a dividend of GBX 10.30 per share on Thursday, March 28th. This represents a yield of 0.54%. The ex-dividend date is Thursday, February 29th. The official announcement can be viewed at this link.
Read our dividend analysis for GNS
.

Is Genus a good dividend stock?

Genus (LON:GNS) pays an annual dividend of GBX 32 per share and currently has a dividend yield of 1.81%. The dividend payout ratio is 6,274.51%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for GNS.

What other stocks do shareholders of Genus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Genus investors own include Clinigen Group (CLIN), Glencore (GLEN), Tesco (TSCO), AstraZeneca (AZN), British American Tobacco (BATS), Cronos Group (CRON), Dairy Crest Group (DCG), Debenhams (DEB), Diageo (DGE) and Experian (EXPN).

How do I buy shares of Genus?

Shares of GNS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:GNS) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners